MercoPress, en Español
Montevideo, November 5th 2024 - 12:32 UTC
Pfizer Uruguay and BioNTech SE said in a release that Uruguay will be receiving 2,700,00 doses of the BNT162b2 vaccine, based on ARNm, against the SARS-CoV-2 and delivery will take place “progressively during 2021”
Get our news on your inbox! Suscribe